In the Literature

In their effort to study the percentage of patients with AS and nr-axSpA who respond to treatment with NSAIDs as proposed by ASAS/EULAR recommendations, the researchers provided 100 patients (50 with AS and 50 with nr-axSpA) with a continuous regimen of NSAID therapy at the maximum recommended or tolerated dose for 4 weeks and then prospectively compared their responses.

  • Pregnancy Outcomes in Ankylosing Spondylitis
  • Prescribing Patterns for JIA in the United Kingdom
  • Sifalimumab Is a Potential New Treatment Approach for Patients with Systemic Lupus Erythematosus
  • Sleep Disturbances Lead to Cognitive Decline
  • Alemtuzumab Demonstrates Superior Outcomes versus Interferon-ß-1a in Relapsing-Remitting Multiple Sclerosis
  • Aprepitant Relieves Nausea Associated with Dihydroergotamine Use for Migraine
  • Positive Effect of Hormone Therapy on Physical Function in Postmenopausal Women with Multiple Sclerosis
  • Impact of Biologic DMARDs Treatment on Risk for Sepsis or Mortality in Patients with Rheumatoid Arthritis
  • Skin Temperature Screenings for Progressive Rheumatoid Arthritis
  • EULAR Revises Its Recommendations for the Management of Fibromyalgia
  • Growing Burden of Arthritis in the United States
  • Patients with Lupus at Risk for End-Stage Renal Disease
  • Multiple Sclerosis Tops Neurology Drug Costs in Medicare Payments
  • Considering a Patient's Immune Status May Improve Treatment Outcomes in Glioblastoma
  • AAN Updates Its Quality Measures for Parkinson's Disease to Improve Patient Care
  • Afatinib Superior to Gefitinib as First-Line Treatment for EGFR Mutation–Positive NSCLC
  • Combination Chemotherapy plus Radiation Prolongs Survival in Low-Grade Glioma
  • Less Frequent Lung Cancer Screening Warranted in Individuals with Negative Initial Screening
  • Oncology Benchmarks Annual Report Shows New Patient Visits, Drug Spending Are Rising
  • Personalizing Therapy for Patients with Multiple Myeloma
Page 1 of 19
Results 1 - 10 of 182
  • Rheumatology Practice Management
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology